LCRF Leading Edge Research Grant 2026: Up to $150,000 for Innovative Lung Cancer Research
The Lung Cancer Research Foundation (LCRF) is now accepting applications for the 2026 Leading Edge Research Grant Program — a prestigious funding opportunity designed to support high-impact, innovative studies that address critical gaps in lung cancer research.
Lung cancer remains the leading cause of cancer deaths worldwide, yet research funding lags behind other cancers. This grant empowers researchers to drive breakthroughs in biology, therapies, detection, and equity.
About the LCRF Leading Edge Research Grant Program
The LCRF Leading Edge Research Grant provides up to $150,000 over two years ($75,000 per year) to fund groundbreaking projects across the full spectrum of lung cancer research, including:
- Lung cancer biology and mechanisms
- Targeted therapies and immunotherapies
- Machine learning and AI applications in oncology
- Health disparities and social determinants of health
- Basic, translational, clinical, epidemiological, and health services research
This program specifically targets innovative, high-risk/high-reward ideas with strong potential to improve prevention, diagnosis, treatment, and quality of life for lung cancer patients.
Who Is Eligible?
The grant is open to researchers at non-profit academic or research institutions worldwide (US-based and international applicants welcome). Key eligibility criteria include:
- Career stage: Post-doctoral researchers, clinical fellows, and early-to-mid-career investigators
- Experience limit: Less than 7 years since initial faculty appointment
Note: Applicants may only submit one LCRF grant application per cycle.
Grant Details at a Glance
| Detail | Information |
|---|---|
| Award Amount | $150,000 total ($75,000/year for 2 years) |
| Indirect Costs | 0% (direct costs only; budgets with overhead will be flagged) |
| Salary Support | Allowed (with strong justification) |
| Project Focus | Innovative lung cancer research across multiple domains |
Application Process and Deadlines (2026 Cycle)
Applications follow a two-stage process via the LCRF portal (Proposal Central):
- Stage 1: Letter of Intent (LOI)
- 1-page Specific Aims
- NIH-format biosketches (PI and key personnel)
- Deadline: March 10, 2026 (midnight)
- Stage 2: Full Proposal (by invitation only)
- Applicants notified: Around April 28, 2026
- Deadline: June 2, 2026
Tip: Start preparing your LOI early — strong, focused Specific Aims are key to advancing to the full proposal stage.
Why Apply for LCRF Funding?
The Lung Cancer Research Foundation is the leading nonprofit dedicated exclusively to lung cancer research. To date, LCRF has funded over 450 grants totaling nearly $53 million — the highest amount from any nonprofit focused on this disease.
By supporting early-career investigators, the Leading Edge program invests in the next generation of lung cancer leaders and helps close the critical funding gap for this underfunded area of oncology.
Ready to Apply?
Visit the official LCRF website for full details, RFP guidelines, and the application portal:
→ LCRF 2026 Funding Opportunities
Don’t miss this opportunity to advance your lung cancer research career and contribute to better outcomes for patients worldwide. Share this post with researchers in your network!